Zumiez Inc. (ZUMZ) Analysts See $0.80 EPS; Syneos Health, Inc. (INCR) Had 8 Bullish Analysts

February 17, 2018 - By Michael Collier

Analysts expect Zumiez Inc. (NASDAQ:ZUMZ) to report $0.80 EPS on March, 8.They anticipate $0.06 EPS change or 8.11% from last quarter’s $0.74 EPS. ZUMZ’s profit would be $20.20 million giving it 6.28 P/E if the $0.80 EPS is correct. After having $0.48 EPS previously, Zumiez Inc.’s analysts see 66.67% EPS growth. It closed at $20.1 lastly. It is down 3.10% since February 17, 2017 and is uptrending. It has underperformed by 13.60% the S&P500.

Among 13 analysts covering INC Research Holdings (NASDAQ:INCR), 8 have Buy rating, 0 Sell and 5 Hold. Therefore 62% are positive. INC Research Holdings had 36 analyst reports since August 14, 2015 according to SRatingsIntel. KeyBanc Capital Markets maintained the stock with “Buy” rating in Monday, November 13 report. The stock has “Buy” rating by Jefferies on Tuesday, September 1. The stock has “Outperform” rating by Robert W. Baird on Friday, November 10. The firm has “Buy” rating by Goldman Sachs given on Friday, August 12. The rating was maintained by Avondale with “Market Perform” on Monday, April 18. On Thursday, July 27 the stock rating was maintained by Jefferies with “Hold”. The stock has “Neutral” rating by Robert W. Baird on Tuesday, May 3. On Monday, June 5 the stock rating was upgraded by KeyBanc Capital Markets to “Buy”. Robert W. Baird maintained the stock with “Buy” rating in Monday, October 9 report. The stock of Syneos Health, Inc. (NASDAQ:INCR) has “Buy” rating given on Wednesday, December 20 by Robert W. Baird. See Syneos Health, Inc. (NASDAQ:INCR) latest ratings:

03/01/2018 Broker: KeyBanc Capital Markets Rating: Buy New Target: $50.0 Maintain
20/12/2017 Broker: Robert W. Baird Rating: Buy New Target: $50.0 Maintain
11/12/2017 Broker: Barclays Capital Rating: Equal-Weight New Target: $40 Initiates Coverage On
30/11/2017 Broker: SunTrust Rating: Buy New Target: $50.0 Maintain
01/12/2017 Broker: Mizuho Rating: Hold New Target: $41.0 Maintain
16/11/2017 Broker: Robert W. Baird Rating: Buy New Target: $46.0 Maintain
14/11/2017 Broker: Credit Suisse Rating: Buy New Target: $54.0 Maintain
13/11/2017 Broker: KeyBanc Capital Markets Rating: Buy New Target: $46.0 Maintain
09/11/2017 Broker: Mizuho Rating: Hold New Target: $57.0 Maintain
10/11/2017 Broker: Robert W. Baird Rating: Outperform Old Target: $67 New Target: $46 Maintain

INC Research Holdings, Inc., a contract research organization, provides various clinical development services for the biopharmaceutical and medical device industries in North America, Europe, the Middle East and Africa, the Asia-Pacific, and Latin America. The company has market cap of $4.23 billion. The firm offers a range of services focusing on Phase I to Phase IV clinical trials in central nervous system, oncology, and other complex therapeutic areas. It currently has negative earnings. The Company’s services include clinical trial management services comprising patient recruitment and retention, project management, clinical monitoring, drug safety/pharmacovigilance, medical affairs, quality assurance, and regulatory and medical writing; and data services consisting of clinical data management, electronic data capture, and biostatistics.

Investors sentiment increased to 1.57 in Q3 2017. Its up 0.27, from 1.3 in 2017Q2. It is positive, as 24 investors sold Syneos Health, Inc. shares while 59 reduced holdings. 33 funds opened positions while 97 raised stakes. 102.50 million shares or 85.12% more from 55.37 million shares in 2017Q2 were reported. Connor Clark & Lunn Invest Management Limited has 0.02% invested in Syneos Health, Inc. (NASDAQ:INCR) for 70,119 shares. 11,191 are held by Tower Capital Ltd Liability Com (Trc). Point72 Asia (Hong Kong) Ltd holds 26 shares. 9,093 are owned by Amer Century Incorporated. 657,210 were reported by Cooke & Bieler Limited Partnership. Citadel Advisors Ltd Com has 113,122 shares. Credit Suisse Ag reported 170,961 shares. Ing Groep Nv invested in 0.01% or 6,884 shares. Arrowmark Colorado holds 1.13% in Syneos Health, Inc. (NASDAQ:INCR) or 1.90M shares. Healthcor Management Limited Partnership invested 1.63% in Syneos Health, Inc. (NASDAQ:INCR). Bank Of America De holds 0% or 238,202 shares. Smith Asset Grp Inc Ltd Partnership owns 462 shares. Swiss Bank & Trust invested in 95,277 shares. Moreover, Profund Advsrs Ltd Liability Company has 0.07% invested in Syneos Health, Inc. (NASDAQ:INCR) for 30,729 shares. Teachers Retirement Of The State Of Kentucky reported 30,682 shares.

The stock decreased 1.94% or $0.8 during the last trading session, reaching $40.5. About 1.48 million shares traded or 5.93% up from the average. Syneos Health, Inc. (NASDAQ:INCR) has risen 27.42% since February 17, 2017 and is uptrending. It has outperformed by 10.72% the S&P500.

Among 21 analysts covering Zumiez Inc. (NASDAQ:ZUMZ), 7 have Buy rating, 2 Sell and 12 Hold. Therefore 33% are positive. Zumiez Inc. had 64 analyst reports since August 5, 2015 according to SRatingsIntel. Jefferies maintained the stock with “Hold” rating in Friday, June 3 report. Robert W. Baird maintained Zumiez Inc. (NASDAQ:ZUMZ) on Thursday, September 7 with “Hold” rating. The rating was maintained by Credit Suisse with “Neutral” on Friday, September 11. On Thursday, October 5 the stock rating was maintained by B. Riley & Co with “Buy”. The stock has “Hold” rating by Jefferies on Wednesday, July 5. The stock has “Neutral” rating by Wedbush on Friday, September 11. Susquehanna upgraded Zumiez Inc. (NASDAQ:ZUMZ) on Monday, August 17 to “Positive” rating. The rating was maintained by Wolf with “Underperform” on Monday, September 14. The firm has “Hold” rating by BMO Capital Markets given on Thursday, June 1. The stock of Zumiez Inc. (NASDAQ:ZUMZ) earned “Fairly Valued” rating by Sterne Agee CRT on Friday, September 11.

Investors sentiment decreased to 1.27 in 2017 Q3. Its down 0.01, from 1.28 in 2017Q2. It worsened, as 20 investors sold Zumiez Inc. shares while 35 reduced holdings. 27 funds opened positions while 43 raised stakes. 18.43 million shares or 8.18% less from 20.07 million shares in 2017Q2 were reported. Kbc Group Incorporated Nv owns 16,706 shares. Employees Retirement Sys Of Texas accumulated 0.03% or 124,000 shares. Metropolitan Life Insur New York holds 14,431 shares or 0% of its portfolio. D E Shaw And invested in 121,914 shares or 0% of the stock. The Georgia-based Invesco has invested 0% in Zumiez Inc. (NASDAQ:ZUMZ). 13,244 are held by Texas Permanent School Fund. Pub Employees Retirement Association Of Colorado holds 0% of its portfolio in Zumiez Inc. (NASDAQ:ZUMZ) for 7,140 shares. Highbridge Ltd Liability Corp accumulated 66,094 shares or 0.02% of the stock. 2,252 were accumulated by Pinebridge Invests L P. Parametric Port Assoc Limited Liability Company holds 0% of its portfolio in Zumiez Inc. (NASDAQ:ZUMZ) for 101,149 shares. Renaissance Techs Limited Liability Com stated it has 328,600 shares. Price T Rowe Assoc Md owns 2.20M shares. Morgan Stanley holds 0% in Zumiez Inc. (NASDAQ:ZUMZ) or 34,487 shares. Morgan Dempsey Cap Management Lc has invested 0.07% in Zumiez Inc. (NASDAQ:ZUMZ). Deutsche Savings Bank Ag stated it has 0% of its portfolio in Zumiez Inc. (NASDAQ:ZUMZ).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Michael Collier

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: